WAYNE, Pa.--(BUSINESS WIRE)--Jun. 10, 2016--
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care, urology and surgery, is committed to
connecting clinicians with technology in a way that improves clinical
practice and advances patient outcomes. Teleflex will present its
innovative intraosseous vascular access system, products for rescue
airway, atomization and intubation needs at the first Social Media and
Critical Care Conference (“SMACC”) in Dublin, Ireland on June 13-16,
2016.
During the event, Teleflex will be part of a global critical care
community that has grown from strong social media connections among the
delegates aiming at excellence in patient care, innovation, teaching and
learning. Teleflex will showcase its Arrow® EZ-IO®
Intraosseous Vascular Access System and other products for rescue
airway, atomization and intubation needs, host a procedural lab and
provide lectures at its booth.
The Arrow® EZ-IO® Intraosseous Vascular Access
System from Teleflex is an innovative and complete solution for rapid
vascular access – whether the emergency responder is facing difficult
vascular access challenges or the need for fast intraosseous access for
critical situations and life-threatening emergencies. This system is
designed to provide the medical professional vascular access to the
central circulation system within seconds1, delivering
medications, intravenous fluids and blood products to adult and
pediatric patients alike.
Teleflex will be sponsoring a procedural lab in partnership with the
American College of Emergency Physicians and SMACC. Resuscitation of the
critically ill is paramount for optimal patient care and outcome, yet it
can be the most stressful and frustrating component of clinical
practice. Resuscitation demands excellence in the provision of quality
invasive procedures, however, the skills that are required to save a
life are often not utilized in a timely, optimal fashion due to lack of
practice, unfamiliarity with the procedure itself or advances in
equipment or technique. At this procedural lab, internationally renowned
instructors will be teaching utilizing actual tissue, making this a low
stress learning environment.
The Teleflex Clinical & Medical Affairs team will be at the booth to
provide lectures on the latest clinical topics and resuscitation
scenarios using high fidelity simulation models in a virtual reality
environment. The team of highly experienced clinicians will demonstrate
the latest, evidence based interventions related to intraosseous needle
placement. These interactive sessions will help educate clinicians from
around the globe, advancing clinical practice and improving patient
outcomes.
During SMACC, Teleflex will also focus on the new LMA®
Protector™ Laryngeal Mask Airway. The LMA® Protector™ Airway
represents a new chapter in Teleflex’s search for the optimum subglottic
airway. With a fully silicone construction, Cuff Pilot™ Technology, dual
gastric channels and the ability to intubate, the LMA® Protector™
Airway is the most advanced second generation airway from Teleflex.
When IV drug delivery is less than ideal, the LMA® MAD Nasal™
Device2 from Teleflex can come to the rescue delivering safe,
painless and rapidly effective treatment. No needle. No trauma. No risk
of needle stick injury. In addition, Teleflex will introduce a range of
laryngoscopes featuring the TruLite Secure™ Single-Use Laryngoscope
blade and handle, complementing our existing Anaesthesia portfolio to
offer complete airway solutions.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, EZ-IO, Hudson RCI, LMA,
LMA Protector, MAD Nasal, Pilling, Rusch, TruLite Secure and Weck are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other countries. © 2016 Teleflex
Incorporated. All rights reserved.
References:
1Von Hoff DD , Kuhn JG, Burris HA, Miller LJ. Does
intraosseous equal intravenous? A pharmacokinetic study. Amer J Emerg
Med 2008;26:31-8
2For use with drugs approved for intranasal delivery
View source version on businesswire.com: http://www.businesswire.com/news/home/20160610005037/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com